bhavana

The report " Infectious Disease Diagnostics Market by Component (Reagents and Kits, Instruments, Services), by Disease Type (HIV, HBV, HCV, TB, HAIs, Respiratory Infections, STDs, COVID-19, Others), by Technology (Immunoassay, Molecular Diagnostics), by End User (Hospitals and Clinics, Diagnostic Centers, Homecare, Others), and Region - Global Forecasts to 2030", is projected to reach USD 34,599.0 million in 2023, having grown at a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period 2024-2030. The growth of the infectious disease diagnostics market drivers shifts in focus from centralized laboratories to decentralized point-of-care testing. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=16253 Competitive Dashboard: The prominent key players operating in the global infectious disease diagnostics market Abbott Laboratories Becton Dickinson and Company BioMerieus SA Bio-Rad Laboratories Danaher Corporation...

The global infectious disease diagnostics market size was valued at USD 14,007.8 million in 2022 and is poised to grow at a significant CAGR of 4.4% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and further split by nations and categories within each region. The research also includes factors and barriers to the infectious disease diagnostics market growth , as well as their impact on the market's future growth. The report gives a comprehensive overview of both primary and secondary data.   View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-infectious-disease-diagnostics-market The global infectious disease diagnostics market segmentation: 1) By Prod...